Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.97 USD | -1.07% | +4.06% | +35.88% |
09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.88% | 643.28Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+50.30% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Price Target on Revolution Medicines to $35 From $31, Maintains Buy Rating